M&A Deal Summary |
|
|---|---|
| Date | 2020-05-19 |
| Target | HintMD |
| Sector | Internet Software and Services |
| Buyer(s) | Revance Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
| Revenue | 234M USD (2023) |
Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for aesthetic and therapeutic categories. Revance Therapeutics was founded in 1999 and is based in Newark, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Internet Software and Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |